Prudential Financial’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.6K | Buy |
22,790
+7,650
| +51% | +$17.7K | ﹤0.01% | 2342 |
|
|
2025
Q1 | $21K | Buy |
15,140
+2,150
| +17% | +$2.99K | ﹤0.01% | 2253 |
|
|
2024
Q4 | $22.5K | Buy |
12,990
+1,800
| +16% | +$3.11K | ﹤0.01% | 2270 |
|
|
2024
Q3 | $22.5K | Hold |
11,190
| – | – | ﹤0.01% | 2690 |
|
|
2024
Q2 | $25.1K | Sell |
11,190
-7,860
| -41% | -$17.6K | ﹤0.01% | 2663 |
|
|
2024
Q1 | $54.7K | Hold |
19,050
| – | – | ﹤0.01% | 2582 |
|
|
2023
Q4 | $33.7K | Buy |
19,050
+1,800
| +10% | +$3.19K | ﹤0.01% | 2585 |
|
|
2023
Q3 | $54.5K | Buy |
+17,250
| New | +$54.5K | ﹤0.01% | 2492 |
|